Research ExplorerScientific StaffEike Christian Burandt Publications

Dr.med. ID: 44324

Eike Christian Burandt

graph of relations
Affiliations
101 - 142 out of 142Page size: 50

Publications

  1. 2019

  2. Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis

    Grimm, D., Prieske, K., Mathey, S., Kuerti, S., Burandt, E., Schmalfeldt, B. & Woelber, L., 03.2019, In: INT J GYNECOL CANCER. 29, 3, p. 466-473 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

    Minner, S., Lutz, J., Hube-Magg, C., Kluth, M., Simon, R., Höflmayer, D., Burandt, E., Tsourlakis, M. C., Sauter, G., Büscheck, F., Wilczak, W., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Jacobsen, F., Hinsch, A., Poos, A., Oswald, M., Rippe, K., König, R. & Schroeder, C., 02.2019, In: PROSTATE. 79, 3, p. 302-311 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

    Mandelkow, T., Blessin, N. C., Lueerss, E., Pott, L., Simon, R., Li, W., Wellge, B., Debatin, N. F., Höflmayer, D., Izbicki, J. R., Büscheck, F., Luebke, A. M., Wittmer, C., Jacobsen, F., Lutz, F., Burandt, E., Steurer, S., Sauter, G., Tsourlakis, M. C., Wilczak, W., Hinsch, A. & Minner, S., 2019, In: DIS MARKERS. 2019, p. 2532518

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

    Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E-C., Steurer, S., Wilczak, W. & Hinsch, A., 2019, In: DIS MARKERS. 2019, p. 5160565

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2018

  7. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

    Li, W., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Pott, L., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S., Wilczak, W. & Hinsch, A., 04.12.2018, In: BMC CANCER. 18, 1, p. 1209

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

    Kluth, M., Scherzai, S., Büschek, F., Fraune, C., Möller, K., Höflmayer, D., Minner, S., Göbel, C., Möller-Koop, C., Hinsch, A., Neubauer, E., Tsourlakis, M. C., Sauter, G., Heinzer, H., Graefen, M., Wilczak, W., Luebke, A. M., Burandt, E., Steurer, S., Schlomm, T. & Simon, R., 10.2018, In: GENE CHROMOSOME CANC. 57, 10, p. 504-512 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer

    Wölber, L., Joosse, S., Grimm, D., Mathey, S., Mahner, S., Burandt, E. C., Klutmann, S., Schmalfeldt, B. & Prieske, K., 19.06.2018, In: INT J GYNECOL CANCER. 28, 7, p. 1403-1409 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

    Heinrich, M-C., Göbel, C., Kluth, M., Bernreuther, C., Sauer, C., Schroeder, C., Möller-Koop, C., Hube-Magg, C., Lebok, P., Burandt, E., Sauter, G., Simon, R., Huland, H., Graefen, M., Heinzer, H., Schlomm, T. & Heumann, A., 31.05.2018, In: BMC CANCER. 18, 1, p. 612

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 2017

  12. Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer

    Prieske, K., Prieske, S., Joosse, S. A., Trillsch, F., Grimm, D., Burandt, E., Mahner, S., Schmalfeldt, B., Milde-Langosch, K., Oliveira-Ferrer, L. & Woelber, L., 10.10.2017, In: ONCOTARGET. 8, 47, p. 83063-83074 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays

    Hinsch, A., Buchholz, M., Odinga, S., Borkowski, C., Koop, C., Izbicki, J. R., Wurlitzer, M., Krech, T., Wilczak, W., Steurer, S., Jacobsen, F., Burandt, E-C., Stahl, P., Simon, R., Sauter, G. & Schlüter, H., 03.2017, In: J MASS SPECTROM. 52, 3, p. 165-173

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 10.01.2017, In: ONCOTARGET. 8, 2, p. 3761

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  15. Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors.

    Oing, C., Dyshlovoy, S., Burandt, E., Amsberg, G. V., Honecker, F., Bokemeyer, C., Rothkamm, K. & Mansour, W. Y., 2017, In: ONCOL RES TREAT. 40, p. 95-96

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  16. 2016

  17. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

    Lebok, P., Roming, M., Kluth, M., Koop, C., Ozden, C., Taskin, B., Hussein, K., Lebeau, A., Witzel, I., Wölber, L., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Müller, V., Schmalfeldt, B., Simon, R., Sauter, G., Terracciano, L., Krech, R. H., von der Assen, A. & Burandt, E., 06.12.2016, In: ONCOTARGET. 7, 49, p. 81322-81331

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: A case report and review of the literature

    Banys-Paluchowski, M., Burandt, E., Banys, J., Geist, S., Sauter, G., Krawczyk, N. & Paluchowski, P., 10.10.2016, In: WORLD J CLIN ONCOL. 7, 5, p. 420-424 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Patterns of distant metastases in vulvar cancer

    Prieske, K., Haeringer, N., Grimm, D., Trillsch, F., Eulenburg, C., Burandt, E., Schmalfeldt, B., Mahner, S., Mueller, V. & Woelber, L., 09.2016, In: GYNECOL ONCOL. 142, 3, p. 427-34 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

    Lebok, P., Huber, J., Burandt, E-C., Lebeau, A., Marx, A. H., Terracciano, L., Heilenkötter, U., Jänicke, F., Müller, V., Paluchowski, P., Geist, S., Wilke, C., Simon, R., Sauter, G. & Quaas, A., 08.2016, In: MOL MED REP. 14, 2, p. 1443-50 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node

    Woelber, L., Eulenburg, C., Grimm, D., Trillsch, F., Bohlmann, I., Burandt, E., Dieckmann, J., Klutmann, S., Schmalfeldt, B., Mahner, S. & Prieske, K., 08.2016, In: ANN SURG ONCOL. 23, 8, p. 2508-14

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer

    Trillsch, F., Kuerti, S., zu Eulenburg, C., Burandt, E., Woelber, L., Prieske, K., Eylmann, K., Oliveira-Ferrer, L., Milde-Langosch, K. & Mahner, S., 12.01.2016, In: BRIT J CANCER. 114, 2, p. 213-220

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Cyclin D1 gene amplification is highly homogeneous in breast cancer

    Burandt, E., Grünert, M., Lebeau, A., Choschzick, M., Quaas, A., Jänicke, F., Müller, V., Scholz, U., Bokemeyer, C., Petersen, C., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, R., Sauter, G. & Wilczak, W., 01.2016, In: BREAST CANCER-TOKYO. 23, 1, p. 111-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2015

  25. Liposarcoma of the breast arising in a malignant phyllodes Tumor: A case report and review of the literature

    Banys-Paluchowski, M., Burandt, E., Quaas, A., Wilczak, W., Geist, S., Sauter, G., Krawczyk, N., Pietzner, K. & Paluchowski, P., 10.10.2015, In: WORLD J CLIN ONCOL. 6, 5, p. 174-8 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 29.09.2015, In: ONCOTARGET. 6, 29, p. 27966-79 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. 8p deletion is strongly linked to poor prognosis in breast cancer

    Lebok, P., Mittenzwei, A., Kluth, M., Özden, C., Taskin, B., Hussein, K., Möller, K., Hartmann, A., Lebeau, A., Witzel, I., Mahner, S., Wölber, L., Jänicke, F., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, R., Sauter, G., Terracciano, L., Krech, R., von der Assen, A., Müller, V. & Burandt, E., 2015, In: CANCER BIOL THER. 16, 7, p. 1080-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Partial PTEN deletion is linked to poor prognosis in breast cancer

    Lebok, P., Kopperschmidt, V., Kluth, M., Hube-Magg, C., Özden, C., Taskin, B., Hussein, K., Mittenzwei, A., Lebeau, A., Witzel, I., Wölber, L., Mahner, S., Jänicke, F., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, R., Sauter, G., Terracciano, L., Krech, R., von der Assen, A., Müller, V. & Burandt, E., 2015, In: BMC CANCER. 15, 1, p. 963

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. 2014

  30. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

    Burandt, E., Bari Noubar, T., Lebeau, A., Minner, S., Burdelski, C., Jänicke, F., Müller, V., Terracciano, L., Simon, R., Sauter, G., Wilczak, W. & Lebok, P., 01.12.2014, In: ONCOL REP. 32, 6, p. 2628-34 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays

    Steurer, S., Singer, J. M., Rink, M., Chun, F., Dahlem, R., Simon, R., Burandt, E., Stahl, P., Terracciano, L., Schlomm, T., Wagner, W., Höppner, W., Omidi, M., Kraus, O., Kwiatkowski, M., Doh, O., Fisch, M., Soave, A., Sauter, G., Wurlitzer, M., Schlüter, H. & Minner, S., 01.11.2014, In: UROL ONCOL-SEMIN ORI. 32, 8, p. 1225-33 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Thecoma of the ovary: a report of 70 cases emphasizing aspects of its histopathology different from those often portrayed and its differential diagnosis

    Burandt, E. & Young, R. H., 01.08.2014, In: AM J SURG PATHOL. 38, 8, p. 1023-32 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype

    Steurer, S., Seddiqi, A. S., Singer, J. M., Bahar, A. S., Eichelberg, C., Rink, M., Dahlem, R., Huland, H., Sauter, G., Simon, R., Minner, S., Burandt, E., Stahl, P. R., Schlomm, T., Wurlitzer, M. & Schlüter, H., 01.05.2014, In: ANTICANCER RES. 34, 5, p. 2255-61 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice

    Burandt, E., Schreiber, M., Stein, A., Minner, S., Clauditz, T. S., Bokemeyer, C., Jänicke, F., Fisch, M., Izbicki, J. R., Knecht, R., Sauter, G. & Stahl, P. R., 01.03.2014, In: GENE CHROMOSOME CANC. 53, 3, p. 228-39 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Invasive Mammakarzinome: Die aktuelle WHO-Klassifikation

    Lebeau, A., Kriegsmann, M., Burandt, E. & Sinn, H-P., 01.02.2014, In: PATHOLOGE. 35, 1, p. 7-17 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. 2013

  37. Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31

    Pogue-Geile, K. L., Kim, C., Jeong, J-H., Tanaka, N., Bandos, H., Gavin, P. G., Fumagalli, D., Goldstein, L. C., Sneige, N., Burandt, E., Taniyama, Y., Bohn, O. L., Lee, A., Kim, S-I., Reilly, M. L., Remillard, M. Y., Blackmon, N. L., Kim, S-R., Horne, Z. D., Rastogi, P., Fehrenbacher, L., Romond, E. H., Swain, S. M., Mamounas, E. P., Wickerham, D. L., Geyer, C. E., Costantino, J. P., Wolmark, N. & Paik, S., 04.12.2013, In: JNCI-J NATL CANCER I. 105, 23, p. 1782-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer

    Quaas, A., Bahar, A. S., Loga, K., Seddiqi, A. S., Singer, J. M., Omidi, M., Kraus, O., Kwiatkowski, M., Trusch, M., Minner, S., Burandt, E., Stahl, P., Wilczak, W., Wurlitzer, M., Simon, R., Sauter, G., Marx, A. & Schlüter, H., 01.10.2013, In: HISTOPATHOLOGY. 63, 4, p. 455-62 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis

    Katt, J., Schwinge, D., Schoknecht, T., Quaas, A., Sobottka, I., Burandt, E., Becker, C., Neurath, M. F., Lohse, A. W., Herkel, J. & Schramm, C., 01.09.2013, In: HEPATOLOGY. 58, 3, p. 1084-93 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. HER2 amplification in squamous cell carcinomas of the vulva

    Choschzick, M., Hess, S., Grob, T., Burandt, E., Wölber, L., Simon, R. & Sauter, G., 01.05.2013, In: HISTOPATHOLOGY. 62, 6, p. 965-7 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  41. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

    Burandt, E. C., Jens, G., Holst, F., Jänicke, F., Müller, V., Quaas, A., Choschzick, M., Wilczak, W., Terracciano, L., Simon, R., Sauter, G. & Lebeau, A., 2013, In: BREAST CANCER RES TR. 137, 3, p. 745-753 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

    Eichelberg, C., Minner, S., Isbarn, H., Burandt, E., Terracciano, L., Moch, H., Kell, A., Heuer, R., Chun, F. K., Sauter, G., Fisch, M. & Tennstedt, P., 2013, In: WORLD J UROL. 31, 4, p. 847-53 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. 2012

  44. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.

    Minner, S., Rump, D., Tennstedt, P., Simon, R., Burandt, E. C., Terracciano, L., Moch, H., Wilczak, W., Bokemeyer, C., Fisch, M., Sauter, G. & Eichelberg, C., 2012, In: CANCER-AM CANCER SOC. 118, 5, p. 1268-1275 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. 2010

  46. [HER2 ASCO guidelines. The answer to everything?].

    Burandt, E. C. & Sauter, G., 2010, In: PATHOLOGE. 31, 2, p. 285-291 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.

    Marx, A., Burandt, E. C., Choschzick, M., Simon, R., Yekebas, E. F., Kaifi, J., Mirlacher, M., Atanackovic, D., Bokemeyer, C., Fiedler, W., Terracciano, L., Sauter, G. & Izbicki, J. R., 2010, In: HUM PATHOL. 41, 11, p. 1577-1585 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

    Minner, S. J. P., Jessen, B., Stiedenroth, L., Burandt, E. C., Köllermann, J., Mirlacher, M., Erbersdobler, A., Eichelberg, C., Fisch, M., Brümmendorf, T., Bokemeyer, C., Simon, R., Steuber, T., Graefen, M., Huland, H., Sauter, G. & Schlomm, T., 2010, In: CLIN CANCER RES. 16, 5, p. 1553-1560 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. 2009

  50. Gene amplification in ductal carcinoma in situ of the breast.

    Burkhardt, L., Grob, T., Hermann, I., Burandt, E. C., Choschzick, M., Jänicke, F., Müller, V., Bokemeyer, C., Simon, R., Sauter, G., Wilczak, W. & Lebeau, A., 2009, In: BREAST CANCER RES TR.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. HER-2/neu analysis in breast cancer bone metastases.

    Zustin, J., Boddin, K., Tsourlakis, M. C., Burandt, E. C., Mirlacher, M., Jänicke, F., Izbicki, J. R., Rüther, W., Rueger, J. M., Bokemeyer, C., Simon, R. & Sauter, G., 2009, In: J CLIN PATHOL. 62, 6, p. 542-546 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. 2007

  53. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections.

    Rohde, H., Burandt, E. C., Siemssen, N., Frommelt, L., Burdelski, C., Wurster, S., Scherpe, S., Davies, A. P., Harris, L. G., Horstkotte, M. A., Knobloch, J. K-M., Ragunath, C., Kaplan, J. B. & Mack, D., 2007, In: BIOMATERIALS. 28, 9, p. 1711-1720 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next